Variant report
Variant | esv1795436 |
---|---|
Chromosome Location | chr19:56268019-56285066 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:305)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:56268125-56268161 | Hela-S3 | cervix: | n/a | chr19:56268130-56268143 |
2 | CEBPB | chr19:56268023-56268280 | A549 | lung: | n/a | chr19:56268130-56268143 |
3 | CEBPB | chr19:56267971-56268186 | K562 | blood: | n/a | chr19:56268130-56268143 |
4 | CEBPB | chr19:56277973-56278182 | K562 | blood: | n/a | chr19:56278128-56278141 |
5 | CTCF | chr19:56282862-56282960 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr19:56277860-56278010 | HAc | cerebellar: | n/a | n/a |
7 | CTCF | chr19:56283320-56283323 | GM10266 | blood: | n/a | n/a |
8 | CTCF | chr19:56270569-56270612 | GM13976 | blood: | n/a | n/a |
9 | CTCF | chr19:56283229-56283313 | GM10266 | blood: | n/a | n/a |
10 | E2F4 | chr19:56270326-56270356 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | ELF1 | chr19:56271182-56271584 | K562 | blood: | n/a | chr19:56271419-56271432 |
12 | PBX3 | chr19:56277927-56278096 | GM12878 | blood: | n/a | n/a |
13 | POLR2A | chr19:56284139-56284358 | A549 | lung: | n/a | n/a |
14 | POLR2A | chr19:56274116-56274147 | A549 | lung: | n/a | n/a |
15 | SPI1 | chr19:56277792-56278107 | GM12878 | blood: | n/a | n/a |
16 | STAT3 | chr19:56276461-56276799 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | STAT3 | chr19:56267962-56268162 | MCF10A-Er-Src | breast: | n/a | chr19:56268133-56268141 |
18 | TBP | chr19:56270440-56270473 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr19:56274428-56274478 | BE2_C | brain: | n/a |
2 | chr19:56270498-56270548 | GM12878 | blood: | n/a |
3 | chr19:56269246-56269296 | U87 | brain: | n/a |
4 | chr19:56270498-56270548 | NT2-D1 | testis: | n/a |
5 | chr19:56269246-56269296 | HNPCEpiC | eye: | n/a |
6 | chr19:56269259-56269309 | NHDF-neo | bronchial: | n/a |
7 | chr19:56274428-56274478 | HUVEC | blood vessel: | n/a |
8 | chr19:56270729-56270779 | HIPEpiC | eye: | n/a |
9 | chr19:56274428-56274478 | HCM | heart: | n/a |
10 | chr19:56269259-56269309 | Hepatocyte | liver: | n/a |
11 | chr19:56270729-56270779 | GM12891 | blood: | n/a |
12 | chr19:56274428-56274478 | U87 | brain: | n/a |
13 | chr19:56269246-56269296 | PFSK-1 | brain: | n/a |
14 | chr19:56270498-56270548 | HIPEpiC | eye: | n/a |
15 | chr19:56270498-56270548 | AoSMC | blood vessel: | n/a |
16 | chr19:56270729-56270779 | HCF | heart: | n/a |
17 | chr19:56269246-56269296 | HAEpiC | amniotic membrane: | n/a |
18 | chr19:56274428-56274478 | NB4 | blood: | n/a |
19 | chr19:56274428-56274478 | SKMC | muscle: | n/a |
20 | chr19:56270729-56270779 | Hepatocyte | liver: | n/a |
21 | chr19:56270729-56270779 | ProgFib | skin: | n/a |
22 | chr19:56270498-56270548 | BE2_C | brain: | n/a |
23 | chr19:56269259-56269309 | U87 | brain: | n/a |
24 | chr19:56270729-56270779 | HRE | kidney: | n/a |
25 | chr19:56269246-56269296 | ovcar-3 | ovarian: | n/a |
26 | chr19:56269246-56269296 | AG10803 | skin: | n/a |
27 | chr19:56274428-56274478 | HIPEpiC | eye: | n/a |
28 | chr19:56269246-56269296 | HCM | heart: | n/a |
29 | chr19:56270729-56270779 | SKMC | muscle: | n/a |
30 | chr19:56270498-56270548 | HL-60 | blood: | n/a |
31 | chr19:56269259-56269309 | SAEC | small airway: | n/a |
32 | chr19:56270498-56270548 | K562 | blood: | n/a |
33 | chr19:56270498-56270548 | Jurkat | blood: | n/a |
34 | chr19:56270729-56270779 | BE2_C | brain: | n/a |
35 | chr19:56274428-56274478 | MCF-7 | breast: | n/a |
36 | chr19:56269259-56269309 | HCM | heart: | n/a |
37 | chr19:56269259-56269309 | HUVEC | blood vessel: | n/a |
38 | chr19:56270498-56270548 | SKMC | muscle: | n/a |
39 | chr19:56270729-56270779 | HRPEpiC | eye: | n/a |
40 | chr19:56270729-56270779 | A549 | lung: | n/a |
41 | chr19:56269246-56269296 | HIPEpiC | eye: | n/a |
42 | chr19:56269259-56269309 | HEEpiC | esophagus: | n/a |
43 | chr19:56270498-56270548 | AG09319 | gingival: | n/a |
44 | chr19:56269259-56269309 | LNCaP | prostate: | n/a |
45 | chr19:56270729-56270779 | BJ | skin: | n/a |
46 | chr19:56270729-56270779 | GM12878 | blood: | n/a |
47 | chr19:56269259-56269309 | PFSK-1 | brain: | n/a |
48 | chr19:56269246-56269296 | SAEC | small airway: | n/a |
49 | chr19:56269246-56269296 | Caco-2 | colon: | n/a |
50 | chr19:56269246-56269296 | AoSMC | blood vessel: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RFPL4AL1 | TF binding region |
RFPL4AP1 | TF binding region |
RFPL4A | TF binding region |
RFPL4AL1 | CpG island |
RFPL4AP1 | CpG island |
RFPL4A | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185103383 | chr19:56268029-56268030 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs539467920 | chr19:56268040-56268041 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs8109283 | chr19:56268045-56268046 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs62126987 | chr19:56268048-56268049 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs541962535 | chr19:56268052-56268053 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs569249539 | chr19:56268060-56268061 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs562238778 | chr19:56268074-56268075 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs2547255 | chr19:56268083-56268084 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs544728906 | chr19:56268086-56268087 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs5028530 | chr19:56268101-56268102 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs564844735 | chr19:56268103-56268104 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs386811101 | chr19:56268106-56268107 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs374840956 | chr19:56268107-56268108 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs74181753 | chr19:56268112-56268113 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs8109382 | chr19:56268117-56268118 | Enhancers Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs549097361 | chr19:56268132-56268133 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs200491013 | chr19:56268136-56268137 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs140113273 | chr19:56268144-56268145 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs533779481 | chr19:56268173-56268174 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs113234402 | chr19:56268176-56268177 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs577064858 | chr19:56268179-56268180 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs142060850 | chr19:56268183-56268184 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs12151283 | chr19:56268195-56268196 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs556091454 | chr19:56268198-56268199 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs112365239 | chr19:56268208-56268209 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs555949466 | chr19:56268243-56268244 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs535528301 | chr19:56268266-56268267 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs574405238 | chr19:56268267-56268268 | Enhancers ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs12151299 | chr19:56268284-56268285 | Enhancers ZNF genes & repeats | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs572673320 | chr19:56268301-56268302 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28666018 | chr19:56268316-56268317 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs368233651 | chr19:56268335-56268336 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375792832 | chr19:56268384-56268385 | Enhancers ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200281725 | chr19:56268410-56268411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12151301 | chr19:56268432-56268433 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs578169234 | chr19:56268441-56268442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143831753 | chr19:56268447-56268448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565148499 | chr19:56268455-56268456 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116282372 | chr19:56268462-56268463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529285201 | chr19:56268464-56268465 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549058805 | chr19:56268485-56268486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376712936 | chr19:56268498-56268499 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532535294 | chr19:56268511-56268512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190027997 | chr19:56268513-56268514 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74591964 | chr19:56268552-56268553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs79887196 | chr19:56268554-56268555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113156810 | chr19:56268574-56268575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs78419801 | chr19:56268583-56268584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs539692080 | chr19:56268588-56268589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549835865 | chr19:56268594-56268595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:56265800-56268200 | Weak transcription | Liver | Liver |
2 | chr19:56267000-56268200 | Weak transcription | Pancreas | Pancrea |
3 | chr19:56268000-56269800 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr19:56268200-56268400 | ZNF genes & repeats | Liver | Liver |
5 | chr19:56268200-56268400 | Enhancers | Pancreas | Pancrea |
6 | chr19:56268400-56272600 | Weak transcription | Liver | Liver |
7 | chr19:56269800-56270200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr19:56270200-56271800 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr19:56272600-56272800 | Active TSS | Liver | Liver |
10 | chr19:56277000-56279600 | Enhancers | Primary monocytes fromperipheralblood | blood |
11 | chr19:56278000-56278200 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
12 | chr19:56279600-56280000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
13 | chr19:56280000-56281800 | Enhancers | Primary monocytes fromperipheralblood | blood |
14 | chr19:56281200-56281800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |